Nuwellis IncNUWE
Price$0.75Intrinsic value$0.8716% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $8.8M+26.0% YoYTTM through 31 Mar 2026
Net Income -$19.1MTTM through 31 Mar 2026
Free Cash Flow -$11.5MTTM through 31 Mar 2026

Margins

Current
Gross Margin70.1%
Operating Margin-150.0%
Net Margin-180.5%

Returns

-150.0%ROE
-60.0%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio1.56x
Net Debt-$2.1Mnet cash position
Cash & Equivalents$2.1M

Quality Metrics

FCF Margin-131.2%
Earnings-Beat Rate50.0%

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
Pediatric+14.0%
View details

Remains a key strategic growth driver with expanded commercial reach and safety design patents.

Heart Failure+8.0%
View details

Focusing on outpatient heart failure expansion supported by favorable CMS reimbursement increases.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.